Chinese Journal of Dermatology ›› 2025, Vol. 58 ›› Issue (9): 797-800.doi: 10.35541/cjd.20250004
• Expert Commentary • Previous Articles Next Articles
Zhang Chengfeng, Jin Shanglin
Received:
2025-01-06
Revised:
2025-03-15
Online:
2025-09-15
Published:
2025-09-01
Contact:
Zhang Chengfeng
E-mail:e3dangdang@hotmail.com
Supported by:
Zhang Chengfeng, Jin Shanglin. New insights into the pathogenesis and clinical therapeutic strategies of melasma[J]. Chinese Journal of Dermatology, 2025, 58(9): 797-800.doi:10.35541/cjd.20250004
[1] | Sarkar R, Bansal A, Ailawadi P. Future therapies in melasma: what lies ahead?[J]. Indian J Dermatol Venereol Leprol, 2020,86(1):8⁃17. doi: 10.4103/ijdvl.IJDVL_633_18. |
[2] | Jo JY, Chae SJ, Ryu HJ. Update on melasma treatments[J]. Ann Dermatol, 2024,36(3):125⁃134. doi: 10.5021/ad.23.133. |
[3] | Chang CC, Wang YJ, Huang L, et al. Photoaging features of melasma: an in vivo layered and quantitative analysis using computer⁃aided detection of cellular resolution full⁃field optical coherence tomography[J]. J Eur Acad Dermatol Venereol, 2024,38(10):e870⁃e873. doi: 10.1111/jdv.19971. |
[4] | Hara Y, Shibata T. Characteristics of dermal vascularity in melasma and solar lentigo[J]. Photodermatol Photoimmunol Photomed, 2024,40(2):e12953. doi: 10.1111/phpp.12953. |
[5] | Ali L, Al Niaimi F. Pathogenesis of melasma explained[J]. Int J Dermatol, 2025,doi: 10.1111/ijd.17718. |
[6] | Kang HY, Bahadoran P, Suzuki I, et al. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution[J]. Exp Dermatol, 2010,19(8):e228⁃e233. doi: 10.1111/j.1600⁃0625.2009.01057.x. |
[7] | Pain S, Berthélémy N, Naudin C, et al. Understanding solar skin elastosis⁃cause and treatment[J]. J Cosmet Sci, 2018,69(3):175⁃185. |
[8] | Kim M, Kim SM, Kwon S, et al. Senescent fibroblasts in melasma pathophysiology[J]. Exp Dermatol, 2019,28(6):719⁃722. doi: 10.1111/exd.13814. |
[9] | Espósito A, Brianezi G, Miot L, et al. Fibroblast morphology, growth rate and gene expression in facial melasma[J]. An Bras Dermatol, 2022,97(5):575⁃582. doi: 10.1016/j.abd.2021.09.012. |
[10] | Kim Y, Kang B, Kim JC, et al. Senescent fibroblast⁃derived GDF15 induces skin pigmentation[J]. J Invest Dermatol, 2020,140(12):2478⁃2486. doi: 10.1016/j.jid.2020.04.016. |
[11] | 中国中西医结合学会皮肤性病专业委员会色素病学组, 中华医学会皮肤性病学分会白癜风研究中心, 中国医师协会皮肤科医师分会色素病工作组. 中国黄褐斑诊疗专家共识(2021版)[J]. 中华皮肤科杂志, 2021,54(2):110⁃115. doi: 10.35541/cjd.20200900. |
[12] | Lee DJ, Lee J, Ha J, et al. Defective barrier function in melasma skin[J]. J Eur Acad Dermatol Venereol, 2012,26(12):1533⁃1537. doi: 10.1111/j.1468⁃3083.2011.04337.x. |
[13] | Castanedo⁃Cázares JP, Cortés⁃García JD, Pérez⁃Coronado G, et al. Skin barrier function and its relationship with IL⁃17, IL⁃33, and filaggrin in malar melasma[J]. Am J Dermatopathol, 2023,45(5):300⁃305. doi: 10.1097/DAD.0000000000002418. |
[14] | Kang HY, Suzuki I, Lee DJ, et al. Transcriptional profiling shows altered expression of wnt pathway⁃ and lipid metabolism⁃related genes as well as melanogenesis⁃related genes in melasma[J]. J Invest Dermatol, 2011,131(8):1692⁃1700. doi: 10.1038/jid. 2011.109. |
[15] | Xu J, Lu H, Luo H, et al. Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma[J]. Pigment Cell Melanoma Res, 2021,34(6):1105⁃1111. doi: 10.1111/pcmr.12984. |
[16] | Örenay ÖM, Sarıfakıoğlu E, Gülekon A. Evaluation of perilipin 2 and melanocortin 5 receptor serum levels with sebogenesis in acne vulgaris patients[J]. Acta Dermatovenerol Alp Pannonica Adriat, 2021,30(1):7⁃9. |
[17] | Abdel⁃Naser MB, Seltmann H, Zouboulis CC. SZ95 sebocytes induce epidermal melanocyte dendricity and proliferation in vitro[J]. Exp Dermatol, 2012,21(5):393⁃395. doi: 10.1111/j.1600⁃0625.2012.01468.x. |
[18] | Abdel⁃Naser MB, Nikolakis G, Zouboulis CC. Preservation of epidermal melanocyte integrity in an ex vivo co⁃culture skin model with sebocytes[J]. Exp Dermatol, 2023,32(7):1063⁃1071. doi: 10.1111/exd.14813. |
[19] | Flori E, Mastrofrancesco A, Mosca S, et al. Sebocytes contribute to melasma onset[J]. iScience, 2022,25(3):103871. doi: 10. 1016/j.isci.2022.103871. |
[20] | Kwon SH, Hwang YJ, Lee SK, et al. Heterogeneous pathology of melasma and its clinical implications[J]. Int J Mol Sci, 2016,17(6):824. doi: 10.3390/ijms17060824. |
[21] | Inomata S, Matsunaga Y, Amano S, et al. Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B⁃exposed hairless mouse[J]. J Invest Dermatol, 2003,120(1):128⁃134. doi: 10.1046/j. 1523⁃1747.2003.12021.x. |
[22] | Na JI, Choi SY, Yang SH, et al. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation[J]. J Eur Acad Dermatol Venereol, 2013,27(8):1035⁃1039. doi: 10.1111/j.1468⁃3083.2012.04464.x. |
[23] | Moon HR, Jo SY, Kim HT, et al. Loratadine, an H1 antihistamine, inhibits melanogenesis in human melanocytes[J]. Biomed Res Int, 2019,2019:5971546. doi: 10.1155/2019/5971546. |
[24] | Lee HJ, Park MK, Lee EJ, et al. Histamine receptor 2⁃mediated growth⁃differentiation factor⁃15 expression is involved in histamine⁃induced melanogenesis[J]. Int J Biochem Cell Biol, 2012,44(12):2124⁃2128. doi: 10.1016/j.biocel.2012.08.020. |
[25] | Grimbaldeston MA, Simpson A, Finlay⁃Jones JJ, et al. The effect of ultraviolet radiation exposure on the prevalence of mast cells in human skin[J]. Br J Dermatol, 2003,148(2):300⁃306. doi: 10.1046/j.1365⁃2133.2003.05113.x. |
[26] | Korhonen J, Siiskonen H, Haimakainen S, et al. Expression of mast cell tryptase and immunoglobulin E is increased in cutaneous photodamage: implications for carcinogenesis[J]. J Dermatolog Treat, 2024,35(1):2307488. doi: 10.1080/09546634. 2024.2307488. |
[27] | Parkinson LG, Toro A, Zhao H, et al. Granzyme B mediates both direct and indirect cleavage of extracellular matrix in skin after chronic low⁃dose ultraviolet light irradiation[J]. Aging Cell, 2015,14(1):67⁃77. doi: 10.1111/acel.12298. |
[28] | Crivellato E, Nico B, Ribatti D. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis[J]. Cancer Lett, 2008,269(1):1⁃6. doi: 10.1016/j.canlet.2008.03.031. |
[29] | Dias J, Lima PB, Cassiano DP, et al. Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double⁃blind, placebo⁃controlled trial[J]. J Eur Acad Dermatol Venereol, 2022,36(2):e123⁃e125. doi: 10.1111/jdv.17692. |
[30] | Espósito A, Cassiano DP, da Silva CN, et al. Update on melasma⁃part Ⅰ: pathogenesis[J]. Dermatol Ther (Heidelb), 2022,12(9): 1967⁃1988. doi: 10.1007/s13555⁃022⁃00779⁃x. |
[31] | Filoni A, Mariano M, Cameli N. Melasma: how hormones can modulate skin pigmentation[J]. J Cosmet Dermatol, 2019,18(2):458⁃463. doi: 10.1111/jocd.12877. |
[32] | Sarkar R, Jain RK, Puri P. Melasma in Indian males[J]. Dermatol Surg, 2003,29(2):204. |
[33] | Panasiti V, Barone M, Coppola R, et al. Expression of estrogen receptors in Spitz and Reed nevi[J]. Ital J Dermatol Venerol, 2021,156(3):378⁃383. doi: 10.23736/S2784⁃8671.19.06376⁃4. |
[34] | Sun M, Xie HF, Tang Y, et al. G protein⁃coupled estrogen receptor enhances melanogenesis via cAMP⁃protein kinase (PKA) by upregulating microphthalmia⁃related transcription factor⁃tyrosinase in melanoma[J]. J Steroid Biochem Mol Biol, 2017,165(Pt B):236⁃246. doi: 10.1016/j.jsbmb.2016.06.012. |
[35] | Wiedemann C, Nägele U, Schramm G, et al. Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro[J]. Contraception, 2009,80(3):292⁃298. doi: 10.1016/j.contraception.2009.03.005. |
[36] | Tadokoro T, Rouzaud F, Itami S, et al. The inhibitory effect of androgen and sex⁃hormone⁃binding globulin on the intracellular cAMP level and tyrosinase activity of normal human melanocytes[J]. Pigment Cell Res, 2003,16(3):190⁃197. doi: 10.1034/j.1600⁃0749.2003.00019.x. |
[37] | He X, Chen L, Jin S, et al. Correlation of biorhythmic disorders with melasma: a cross⁃sectional survey[J]. J Am Acad Dermatol, 2025,92(1):185⁃187. doi: 10.1016/j.jaad.2024.09.050. |
[38] | Sarkar S, Porter KI, Dakup PP, et al. Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells[J]. Pigment Cell Melanoma Res, 2021,34(5):955⁃965. doi: 10.1111/pcmr.12998. |
[39] | Hardman JA, Tobin DJ, Haslam IS, et al. The peripheral clock regulates human pigmentation[J]. J Invest Dermatol, 2015,135(4):1053⁃1064. doi: 10.1038/jid.2014.442. |
[40] | Sampaio Xerfan EM, Andersen ML, Tomimori J, et al. Melasma and the possible interaction with sleep quality[J]. J Clin Aesthet Dermatol, 2020,13(11):12. |
[41] | He X, Jin S, Dai X, et al. The emerging role of visible light in melanocyte biology and skin pigmentary disorders: friend or foe?[J]. J Clin Med, 2023,12(23):7488. doi: 10.3390/jcm12237488. |
[42] | Fonken LK, Nelson RJ. The effects of light at night on circadian clocks and metabolism[J]. Endocr Rev, 2014,35(4):648⁃670. doi: 10.1210/er.2013⁃1051. |
[1] | Zhou Miaoni, Sheng Anqi, Fu Lifang, Jin Rong, Xu Wen, Wei Xiaodong, Xu Ai′e . Efficacy and safety of an antioxidant gel containing tea polyphenols combined with narrow-band ultraviolet B in the treatment of vitiligo: a single-center randomized controlled trial [J]. Chinese Journal of Dermatology, 2025, 58(9): 834-838. |
[2] | Duan Bolin, Li Qianwen, Le Yue, Geng Mengmeng, Luo Longfei, Lei Tiechi. Rutin inhibits ultraviolet irradiation-induced dermal fibroblast senescence and melanogenesis in mouse ear skin [J]. Chinese Journal of Dermatology, 2025, 58(9): 801-807. |
[3] | Xu Zhongyi, Xing Xiaoxue, Dong Yaqi, Zhang Chengfeng, Xiang Leihong. Retrospective analysis of clinical manifestations and treatment outcomes in 254 patients with melasma in a tertiary grade-A hospital in Shanghai [J]. Chinese Journal of Dermatology, 2025, 58(9): 808-815. |
[4] | He Muyang, Jin Shanglin, Zhang Chengfeng. Roles of sex hormones and underlying mechanisms in the pathogenesis of melasma [J]. Chinese Journal of Dermatology, 2025, 58(9): 863-867. |
[5] | Wang Chen, Ding Yuecen, Dong Yaqi, Zhang Chengfeng, Xiang Leihong, Xu Zhongyi. Diagnosis and treatment of acquired dermal macular hyperpigmentation [J]. Chinese Journal of Dermatology, 2025, 58(9): 873-877. |
[6] | Jiang Ziqi, Zhong Judan, Chen Tingqiao, Chen Jin. Pathogenesis and treatment of melasma [J]. Chinese Journal of Dermatology, 2025, 58(9): 868-872. |
[7] | Meng Xiao, Wang Junhui, Yan Zhifang, Wang Ning, Cui Bingnan. Evaluation of efficacy of a Chinese herbal mask in the treatment of melanized-type melasma by stereological measurements [J]. Chinese Journal of Dermatology, 2025, 58(1): 53-59. |
[8] | Ai Fangting, Sun Zijun, Miao Guoying, Yao Chunxia. Role of calcium-sensing receptors in the pathophysiology of skin of the elderly [J]. Chinese Journal of Dermatology, 2025, 58(1): 76-79. |
[9] | Zhang Jiaqi, Wu Fan, Han Yuqing, Liu Qi, Pan Yao. Application of multi-photon microscopy in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(9): 857-862. |
[10] | Michèle Verschoore, Niu Yueqing, Stéphane Commo, Léopold Muller, Wei Yuhao, Zhen Yaxian, Liu Wei. Chinese Medical Association-L′Oréal China Skin & Hair Research Grant result summary—skin [J]. Chinese Journal of Dermatology, 2024, 57(5): 464-467. |
[11] | Ma Tongchuan, Deng Tingyue, Xiao Fengli. Associations between smoking and atopic dermatitis [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220793-e20220793. |
[12] | Liu Yingying, Deng Danqi. Correlations between skin microbiome and skin tumors [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230241-e20230241. |
[13] | Dai Xiaoxi, Hu Yu, Chen Kun. Clinical research progress on sunscreens in photodermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230754-e20230754. |
[14] | Sun Jiayi, Song Xiuzu. Role of transient receptor potential vanilloid type 4 channel in skin diseases [J]. Chinese Journal of Dermatology, 2024, 57(12): 1149-1152. |
[15] | Yuan Xingang, Ni Sili, Zhang Jian, Luo Xiaoyan, Wang Hua. Improving diagnosis and treatment of melanocytic nevi in children: an urgent need [J]. Chinese Journal of Dermatology, 2023, 56(8): 782-786. |
|